Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Articaine vs Mepivacaine in 3-year-old children
NCT05839548Phase 3Active, not recruiting
- Sponsor
- Qassim Health Cluster
- Start
- Jul 2023
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of articaine in dental caries, pulpitis, sponsored by Qassim Health Cluster. Started Jul 2023; status: active, not recruiting.
02
Drugs
articaine
03
Conditions
dental cariespulpitis
Beyond the preview
Go deeper on NCT05839548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05839548.